Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FJK36
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,885
Award facts
- Contract value 100% obligated
- $38,885.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,885.45 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 mg/2 mL syringes on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DUPIXENT (dupilumab) is a prescription biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eczema, and other inflammatory conditions, making this a specialized pharmaceutical procurement supporting federal healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition and its established relationship with DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FJK36?
SPE2DB25FJK36 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FJK36 worth?
The government has obligated $38,885 on SPE2DB25FJK36.
Is contract SPE2DB25FJK36 an order under another contract?
Yes. SPE2DB25FJK36 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJK36 competed?
The extent of competition for SPE2DB25FJK36 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award